Biotronik today shared preclinical results for its LivIQ leadless pacemaker system at Heart Rhythm Society (HRS) 2026 in ...
Over the last weekend, Chicago played host to the 2026 edition of the Heart Rhythm Society's annual conference (HRS 2026).
Four late-breaking presentations at Heart Rhythm Society 2026 in Chicago highlight strong clinical evidence across Abbott's ...
NEW ORLEANS, May 20, 2023 /PRNewswire/ -- Abbott today announced late-breaking results from the AVEIR™ dual-chamber (DR) i2i™ Investigational Device Exemption (IDE) study, a large-scale study to ...
Hosted on MSN
BIOTRONIK begins trial of LivIQ pacemaker system
BIOTRONIK has commenced its global pivotal trial assessing the LivIQ leadless pacemaker system, a next-generation single device solution intended for delivering atrioventricular (AV) synchrony through ...
PORTLAND, Ore (KOIN) – On behalf of our sponsors at Abbott, we’re learning about how a medical breakthrough is transforming the way we treat abnormal heart rhythms and one Boston mother’s story shows ...
Medtronic and Biotronik both took steps forward this week with their pacemaker hardware designed to target newly emerging geography in the heart, for delivering electric signals that more closely ...
According to BCC Research, the global market is projected to grow at a CAGR of 5.7%, supported by increasing cardiovascular disease prevalence and technological advancements in implantable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results